Doctor Who Fought 8 Years for Children’s Lives Now Hit with Legal Notice
Hyderabad paediatrician Dr. Sivaranjani Santosh, who advocated for clearer ORS labelling, receives legal notice from companies linked to Kenvue and Johnson & Johnson.
Johnson & Johnson’s New Blood Cancer Drug Gets Fast Track FDA Approval
Johnson & Johnson’s New Blood Cancer Drug Gets Fast Track FDA Approval
The FDA grants fast track approval to Johnson & Johnson’s TECVAYLI and DARZALEX FASPRO combination for relapsed multiple myeloma, offering improved survival outcomes.
Read More
